SIGA Technologies, Inc. (SIGA) は上場企業です ヘルスケア セクターの Drug Manufacturers - Specialty & Generic 業界で事業展開. 本社所在地は New York City, NY, アメリカ. 現CEOは Diem Nguyen.
SIGA を有する IPO日 1997-09-10, 46 名の正社員, に上場 NASDAQ Global Market, 時価総額 $336.73M.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
